Harnessing AI to Address Global Health Challenges with Cambridge Consultants

Title

Harnessing AI to Address Global Health Challenges with Cambridge Consultants

News Releases - Sep. 25, 2019

The innovation specialists at Cambridge Consultants have developed BacillAi, a concept system that harnesses Artificial Intelligence (AI) and standard, low-cost hardware to improve treatment monitoring of tuberculosis (TB) in resource-limited countries. With TB the second largest cause of death by infectious disease in the developing world, the BacillAi system is part of Cambridge Consultants’ continuing mission to move AI beyond the hype, addressing practical, high-impact challenges and improving lives on a global scale.

Upcoming Events

Jul. 17, 2020

Micromobility America

Other News

Cambridge Companies Unite to Meet the COVID-19 Ventilator Challenge

On March 13th, a group of leading medical device development companies from Cambridge, including our colleagues at Cambridge Consultants, was asked by the UK Government to assist in the rapid development and manufacture of ventilators to meet incr

Utilizing the Ava Bracelet to Diagnose and Monitor Symptoms Potentially Related to COVID-19

Our friends over at Ava are working to find out if the Women's Health Br

Synapse Joins MediaTek's Rich IoT Ecosystem as a Hardware Design Partner

In January, Synapse joined MediaTek's Rich IoT program as a preferred ecosystem partner.